Niowave Recovers Radium In a remarkable display of international collaboration and scientific progress, Niowave, Inc.’s Dr. William Peters’ recent trip to Fiji represents a significant milestone in global health and safety. The mission to recover Radium-226 sources, once used in medical treatments, underscores the importance of responsible management of radioactive materials. The successful operation, conducted [...]
BURLINGTON, Mass. and LANSING, Mich., Aug. 12, 2024 /PRNewswire/ -- QSA Global, Inc. (QSA) and Niowave, Inc. (Niowave) are pleased to announce a partnership to transfer Niowave's innovative radium-226 (Ra-226) processing technology to QSA and Co-Develop a Scalable Radium Purification Process. This strategic partnership marks a significant advancement in the field of radiopharmaceutical technology, [...]
Fusion Pharmaceuticals and Niowave Announce Actinium-225 Collaboration and Supply Agreement HAMILTON, ON and BOSTON and LANSING, Mich., June 10, 2022 /PRNewswire/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radio pharmaceuticals as precision medicines, and Niowave, Inc., a manufacturer of medical radioisotopes from radium and uranium, today announced that [...]
